DPP-4 inhibitor with diazine structure

A technology of isomers and compounds, applied in the field of organic synthesis, can solve the problems of inability to meet clinical needs and limited varieties

CN103626775BActive Publication Date: 2015-05-20NANJING HUAWE MEDICINE TECH DEV
3 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Publication Date
2015-05-20

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention provides a novel dipeptidyl peptidase IV (DPP-4) inhibitor type compound. The compound and optical isomers thereof, as well as pharmaceutically acceptable inorganic or organic salt can be used for treating diabetes, particularly non-insulin dependent diabetes and other diseases relevant to DPP-4. The definition of the substituent groups in the general formula (I) is the same as that in the specification.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of organic synthesis, and specifically relates to a dipeptidyl peptidase IV (hereinafter referred to as DPP-4) inhibitor compound with a diazine structure and its application for treating and preventing diabetes and other diseases related to DPP-4. Background technique

[0002] Diabetes is a chronic metabolic disease caused by various pathogenic factors such as genetic factors, immune dysfunction, microbial infection and its toxins, free radical toxins, and mental factors. Clinically, it is characterized by hyperglycemia. Can be divided into type 1 diabetes (insulin-dependent), type 2 diabetes (non-insulin-dependent), gestational diabetes and other special types of diabetes. Type 2 diabetes accounts for about 95% of diabetic patients.

[0003] At present, the main oral hypoglycemic drugs are: sulfonylureas (SU), biguanides, α-glucosidase inhibitors, non-sulfonylurea insulin secretory drugs and insulin sensitizers thi...

Examples

Embodiment example 1

[0074] first step:

[0075]

[0076] Add 8.8g of NaOH and 180ml of methanol to a 250ml single-necked bottle in turn, stir at room temperature to dissolve, add 20.5g of compound (1), heat the oil bath to reflux, TLC (PE:EA=2:1, 2 drops of acetic acid) track the completion of the reaction, Naturally cooled to room temperature, concentrated under reduced pressure to remove the solvent, dissolved the solid in water, adjusted the pH<3 with hydrochloric acid, precipitated a large amount of off-white solid, filtered it with suction, washed the filter cake with water, and dried in vacuo at 45°C to obtain 18 g of a white solid, which is compound (2 ).

[0077] Step two:

[0078]

[0079] Add 0.5g of compound (2), 10ml of DMF, 0.86g of triethylamine, 115g of HOBT and 1.63g of EDC·HCl into a 100ml single-necked flask, stir at room temperature for 1 hour, then add 0.44g of p-chloroaniline, and react overnight at room temperature. TLC (PE:EA=2:1) ​​followed the completion of the re...

Embodiment example 2

[0092] first step:

[0093]

[0094] Add 0.2g of compound (2) to a 500ml single-necked bottle, add 230ml of methanol to dissolve it, then add 0.05g of Pd / C, and after hydrogen replacement for three times, hydrogenate at 35°C under normal pressure. TLC (DCM:MeOH=10:1, adding acetic acid) tracked the completion of the reaction, filtered with suction, and spin-dried the organic phase to obtain 0.18 g of white solid, which was directly used in the next step.

[0095] Step two:

[0096]

[0097] Add 0.56g of compound (5), 20ml of DMF, 0.43g of triethylamine, 0.169g of HOSU and 0.4g of EDC·HCl into a 100ml three-neck flask, stir at room temperature for 1h, add 0.25g of compound (7), and react overnight at 31°C. TLC (DCM:MeOH=40:1, 2 drops of acetic acid) tracked the completion of the reaction, poured the reaction solution into 200ml ice water, a small amount of solid precipitated, adjusted the pH<4 with HCl, extracted three times with EA, combined the organic phases, and washed...

Embodiment 3

[0104] first step:

[0105]

[0106] Add 0.5g of compound (2), 10ml of DMF, 0.86g of triethylamine, 1.15g of HOBT and 1.63g of EDC·HCl into a 100ml single-necked flask, stir at room temperature for 1h, add 0.45g of Boc-hydrazine, and react overnight at 31°C. TLC (PE:EA=1:2, 2 drops of acetic acid) followed the completion of the reaction. Pour the reaction solution into 200ml of ice water to form a yellow solution, extract it three times with EA, combine the organic phases, wash with saturated brine, then dry with anhydrous sodium sulfate for 2 hours, filter with suction, and distill off the solvent under reduced pressure to obtain a red oil 1 g was used directly in the next reaction.

[0107] Step two:

[0108]

[0109] Add 20ml of methanol and 0.1g of Pd / C to a 100ml single-necked bottle containing 1g of compound (10). After three hydrogen replacements, hydrogenation is carried out at normal pressure, and the temperature of the oil bath is controlled at 31°C to react ...